Yuki Furukawa

10PUBLICATIONS
19CO-AUTHORS
Child and adolescent developmentToxicology (incl. clinical toxicology)Psychiatry (incl. psychotherapy)Psychological methodology, design and analysisEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 08, 2025
Side effect profile and comparative tolerability of newer generation antidepressants in the acute treatment of major depressive disorder in children and adolescents: protocol for a systematic review and network meta-analysis.

Cagdas Türkmen, Seda Sacu, Yuki Furukawa

|May 10, 2025
Optimal Dose of Baclofen for the Treatment of Alcohol Use Disorder: A Systematic Review and Dose-Response Meta-analysis.

Kazumasa Kotake, Ryuhei So, Nozomu Hashimoto

|Aug 29, 2024
Optimal dose of vortioxetine: High dose (≥20 mg) is overestimated, lower dose (5-10 mg) may be enough for many.

Yuki Furukawa

|Aug 27, 2024
Initial treatment choices for long-term remission of chronic insomnia disorder in adults: a systematic review and network meta-analysis.

Yuki Furukawa, Masatsugu Sakata, Toshiaki A Furukawa

|Jun 13, 2024
Comparative Efficacy and Acceptability of Treatment Strategies for Antipsychotic-Induced Akathisia: A Systematic Review and Network Meta-analysis.

Yuki Furukawa, Kota Imai, Yusuke Takahashi

|Mar 22, 2023
Optimal duration of antibiotic treatment for community-acquired pneumonia in adults: a systematic review and duration-effect meta-analysis.

Yuki Furukawa, Yan Luo, Satoshi Funada

Pageof 2

Frequent Collaborators

4 joint publications

Toshiaki A Furukawa

2 joint publications

Andrea Cipriani

2 joint publications

Georgia Salanti

2 joint publications

Orestis Efthimiou